Details of the Drug Excipient
General Information of Drug Inactive Ingredient (DIG) (ID: E00106)
| DIG Name |
Histidine
|
||||
|---|---|---|---|---|---|
| Synonyms |
L-histidine; histidine; 71-00-1; H-His-OH; glyoxaline-5-alanine; Anti-rheuma; L-(-)-Histidine; Istidina; S-Histidine; (L)-Histidine; Histidine (VAN); histidina; (S)-4-(2-Amino-2-carboxyethyl)imidazole; Histidinum; L-Histidin; (S)-alpha-amino-1H-imidazole-4-propanoic acid; HISTIDINE, L-; Histidine [USAN:INN]; Histidinum [INN-Latin]; (S)-Histidine; Histidina [INN-Spanish]; (2S)-2-amino-3-(1H-imidazol-4-yl)propanoic acid; L-beta-(4-Imidazolyl)alanin; 4-(2-Amino-2-carboxyethyl)imidazole; FEMA No. 3694; his; L-hystidine; 1H-Imidazole-4-alanine, (S)-; (S)-2-Amino-3-(4-imidazolyl)propionsaeure; L-beta-(4-Imidazolyl)-alpha-alanin; (S)-2-Amino-3-(4-imidazolyl)propionic acid; MFCD00064315; (S)-alpha-Amino-1H-imidazole-4-propionic acid; L-His; L-Alanine, 3-(1H-imidazol-4-yl)-; 7006-35-1; UNII-4QD397987E; AI3-26558; alpha-Amino-4(or 5)-imidazolepropionic acid; alpha-Amino-1H-imidazole-4-propionic acid, (S)-; 1H-Imidazole-4-propanoic acid, alpha-amino-, (S)-; (S)-a-Amino-1H-imidazole-4-propanoic acid; CHEBI:15971; 4QD397987E; L-Histidine, 98%; Polyhistidine; L-2-Amino-3-(4-imidazolyl)propionic acid; Histidine (L-Histidine); Histidine, monohydrochloride; Poly(L-histidine); HSDB 1810; (2S)-2-azanyl-3-(1H-imidazol-5-yl)propanoic acid; EINECS 200-745-3; NSC 137773; L-Hisidine; 1hsl; 1lag; NSC-137773; [3H]histidine; Histidine,(S); [3H]-histidine; 26062-48-6; Histidine metabolism; zlchem 242; (2S)-2-amino-3-(1H-imidazol-4-yl)propanoic acid hydrochloride; L-His-OH; 2-Amino-3-(1H-imidazol-4-yl)-propionic acid; Histidine (USP/INN); L-Histidine (JP17); L-Histidine, homopolymer; Lopac-H-8125; bmse000039; bmse000976; bmse001015; L-Histidine (H-His-OH); amino-4-imidazoleproprionate; SCHEMBL3259; Lopac0_000566; US9138393, Histidine; US9144538, Histidine; (S)1H-Imidazole-4-alanine; CHEMBL17962; (2S)-2-amino-3-(1H-imidazol-5-yl)propanoic acid; (S)-1H-Imidazole-4-alanine; BDBM7953; GTPL3310; GTPL4670; L-Histidine, non-animal source; Imidazole C-4(5) deriv. 5; amino-4-imidazoleproprionic acid; DTXSID9023126; amino-1H-imidazole-4-propanoate; L-Histidine, p.a., 98.5%; ZLC0051; BDBM181118; L-Histidine, Cell Culture Reagent; 3-(1H-imidazol-4-yl)-L-Alanine; HY-N0832; ZINC6661227; amino-1H-imidazole-4-propanoic acid; ANW-35982; AKOS015854051; AKOS026676613; AM81801; CCG-204656; CS-7781; DB00117; MCULE-4083000888; SDCCGSBI-0050549.P002; (S)-a-Amino-1H-imidazole-4-propanoate; NCGC00015518-01; NCGC00162189-01; NCGC00162189-02; NCGC00162189-05; AS-14171; (S)-alpha-Amino-1H-imidazole-4-propanoate; (S)-alpha-Amino-1H-imidazole-4-propionate; L-Histidine, BioUltra, >=99.5% (NT); L-Histidine, SAJ special grade, >=98.5%; S3989; (S)-2-Amino-3-(imidazol-4-yl)propanoic acid; C00135; D00032; H-2310; L-Histidine, ReagentPlus(R), >=99% (TLC); M02982; (2S)-2-amino-3-(imidazol-4-yl)propanoic acid; 88842-EP2289892A1; 88842-EP2305825A1; L-Histidine, Vetec(TM) reagent grade, >=99%; (S)-2-amino-3-(1H-imidazol-4-yl)propanoic acid; 064H315; A836759; Q485277; B81AEDB0-EACA-4296-9BAB-52D60F137FFB; 1H-Imidazole-4-propanoic acid, .alpha.-amino-, (S)-; F8881-8926; F8889-0575; L-Histidine, certified reference material, TraceCERT(R); Z955123622; Histidine, European Pharmacopoeia (EP) Reference Standard; UNII-0O72R8RF8A component HNDVDQJCIGZPNO-YFKPBYRVSA-N; UNII-N7U7BXP2OI component HNDVDQJCIGZPNO-YFKPBYRVSA-N; UNII-QU6SDF3Q03 component HNDVDQJCIGZPNO-YFKPBYRVSA-N; L-Histidine, United States Pharmacopeia (USP) Reference Standard; L-Histidine, Pharmaceutical Secondary Standard; Certified Reference Material; L-Histidine, cell culture tested, meets EP, USP testing specifications, from non-animal source; L-Histidine, PharmaGrade, Ajinomoto, EP, USP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture
|
||||
| DIG Function |
Antioxidant; Buffering agent
|
||||
| Formula |
C6H9N3O2
|
||||
| Canonical SMILES |
C1=C(NC=N1)C[C@@H](C(=O)O)N
|
||||
| InChI |
1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/t5-/m0/s1
|
||||
| InChIKey |
HNDVDQJCIGZPNO-YFKPBYRVSA-N
|
||||
| Physicochemical Properties | Molecular Weight | 155.15 | Topological Polar Surface Area | 92 | |
| XlogP | -3.2 | Complexity | 151 | ||
| Heavy Atom Count | 11 | Rotatable Bond Count | 3 | ||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 4 | ||
Full List of Drug(s) Co-administrated with This DIG